Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters
- PMID: 2335574
- DOI: 10.1210/jcem-70-5-1330
Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters
Abstract
The bone mineral density (BMD) of the lumbar spine (L1-L4) was measured by dual energy x-ray absorptiometry (Hologic QDR 1000) in 135 healthy caucasian children, aged 1-15 yr, and values were correlated with age, height, weight, body surface, bone age, pubertal status, calcium intake, vitamin D supplementation, and serum bone gla protein. BMD increased with age in children of both sexes (r = 0.88; P less than 0.001) from 0.446 +/- 0.048 g/cm2 at 1 yr to 0.625 +/- 0.068 g/cm2 at 10 yr and 0.891 +/- 0.123 g/cm2 at 15 yr of age. The increase was steeper at the time of puberty, reaching values above 0.80 g/cm2 after puberty was achieved. There were no significant differences between boys and girls, except at the age of 12 yr when BMD was higher in girls than in boys (P = 0.007), probably because of the earlier onset of puberty in females. BMD was also highly correlated with height, weight, body surface, and bone age. BMD was not correlated with calcium intake when age was held constant, nor with vitamin D supplementation. Serum bone gla protein showed a steady increase during childhood, with peak values at 11-12 yr of age, and was weakly but significantly correlated with BMD (r = 0.27; P = 0.007). Because of low irradiation exposure, rapid scanning, and high precision, dual energy x-ray absorptiometry is a noninvasive method which is well adapted to the child. It should be helpful in the investigation and follow-up of children with diseases impairing bone metabolism.
Similar articles
-
Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.J Clin Endocrinol Metab. 1996 Mar;81(3):1248-53. doi: 10.1210/jcem.81.3.8772607. J Clin Endocrinol Metab. 1996. PMID: 8772607
-
Vertebra and femur neck bone mineral density values in healthy Turkish children.Turk J Pediatr. 2004 Oct-Dec;46(4):298-302. Turk J Pediatr. 2004. PMID: 15641261
-
Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.J Clin Endocrinol Metab. 1992 Oct;75(4):1060-5. doi: 10.1210/jcem.75.4.1400871. J Clin Endocrinol Metab. 1992. PMID: 1400871
-
Influence of developmental and hormonal factors on bone health in adolescent females: a cross-sectional study and review of the literature.J Pediatr Endocrinol Metab. 2013;26(3-4):239-46. doi: 10.1515/jpem-2012-0355. J Pediatr Endocrinol Metab. 2013. PMID: 23327822 Review.
-
Sex steroids and the acquisition of bone mass.Horm Res. 1997;48 Suppl 5:65-71. doi: 10.1159/000191331. Horm Res. 1997. PMID: 9434047 Review.
Cited by
-
Comparing a common clavicle maturation-based age estimation method to ordinary regression analyses with quadratic and sex-specific interaction terms in adolescents.Sci Rep. 2024 Feb 2;14(1):2754. doi: 10.1038/s41598-024-52980-x. Sci Rep. 2024. PMID: 38307929 Free PMC article.
-
Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study).Osteoporos Int. 2005 Sep;16(9):1036-41. doi: 10.1007/s00198-004-1795-y. Epub 2004 Dec 23. Osteoporos Int. 2005. PMID: 15616757 Clinical Trial.
-
The peak bone mass concept: is it still relevant?Pediatr Nephrol. 2004 Aug;19(8):825-31. doi: 10.1007/s00467-004-1465-5. Epub 2004 Jun 9. Pediatr Nephrol. 2004. PMID: 15197638 Review.
-
Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study.J Inherit Metab Dis. 2003;26(4):371-84. doi: 10.1023/a:1025111220095. J Inherit Metab Dis. 2003. PMID: 12971425
-
The effect of intradialytic exercise on calcium, phosphorus and parathyroid hormone: a randomized controlled trial.BMC Nephrol. 2023 Sep 20;24(1):276. doi: 10.1186/s12882-023-03327-7. BMC Nephrol. 2023. PMID: 37730530 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical